Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FJ5BK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,592
Award facts
- Contract value 100% obligated
- $16,591.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes with a ceiling value of $16,591.88. Issued on September 17, 2025, with an ultimate completion date of September 18, 2025, this firm fixed-price delivery order represents a competitively awarded, non-set-aside contract for pharmaceutical products to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp serves military healthcare systems and other government agencies through this comprehensive global pharmaceutical support vehicle. The company's extensive portfolio of federal medical supply contracts with the DLA demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains. This specific delivery order for Actemra, a rheumatoid arthritis treatment, exemplifies the company's role in supplying specialized medications essential to military and federal healthcare operations. The firm fixed-price structure and streamlined completion timeline reflect the urgent nature of pharmaceutical procurement within federal supply chains.
Quick answers
Who was awarded contract SPE2DB25FJ5BK?
SPE2DB25FJ5BK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FJ5BK worth?
The government has obligated $16,592 on SPE2DB25FJ5BK.
Is contract SPE2DB25FJ5BK an order under another contract?
Yes. SPE2DB25FJ5BK is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5BK competed?
The extent of competition for SPE2DB25FJ5BK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award